|
業務類別
|
Biotechnology |
|
業務概覽
|
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects. |
| 公司地址
| 256 East Grand Avenue, Suite 104, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 405-4770 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.bridgebio.com |
| 員工數量
| 92 |
| Dr. Pedro J. Beltran, PhD |
Director, President and Chief Executive Officer |
-- |
23/04/2026 |
| Mr. Marc Cobo |
Principal Accounting Officer, Vice President, Finance and Controller |
-- |
23/04/2026 |
| Dr. Yong Ben, M.D. |
Chief Medical and Development Officer |
美元 525.30K |
28/04/2026 |
| Mr. Idan Elmelech |
Chief Operating Officer and Principal Financial Officer |
-- |
23/04/2026 |
|
|
| Dr. Frank P. McCormick, D.Sc.,F.R.S.,PhD |
Independent Director |
28/04/2026 |
| Dr. Pedro J. Beltran, PhD |
Director, President and Chief Executive Officer |
23/04/2026 |
| Mr. Jacob Bauer, M.B.A. |
Co-Chairman of the Board |
28/04/2026 |
| Ms. Bihua Chen, M.B.A. |
Director |
28/04/2026 |
| Dr. Neil Kumar, PhD |
Executive Chairman of the Board |
23/04/2026 |
| Dr. Raymond Kelleher, M.D.,PhD |
Independent Director |
28/04/2026 |
| Dr. Praveen Tipirneni, M.B.A.,M.D. |
Independent Director |
28/04/2026 |
| Dr. Peter F Lebowitz, M.D.,PhD |
Independent Director |
26/03/2026 |
|
|
|
|
